Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens Boots Alliance has experienced the latest shakeup in its leadership team, with Chief Information Officer (CIO) Hsiao Wang departing from the company about a year after assuming the role. Wang had been on a leave of absence but is no longer with the drugstore chain, Bloomberg reported Monday (Oct.

Walgreens Leadership Shakeup Continues With CIO Departure

Cooler Screens, a company that sells digital advertising space on refrigerator door screens, is reportedly involved in a legal dispute with Walgreens. The dispute arose after Walgreens installed Cooler Screens' technology, which replaces traditional cooler doors with digital screens that play targeted ads, The Wall Street Journal (WSJ) reported Monday (Oct. 2).

Walgreens and Cooler Screens Clash Over Digital Advertising Technology

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is hosting a myW days member exclusive event October 4 through October 7 offering extraordinary bonus offers and Walgreens Cash rewards instore and online. Members can start clipping offers now to their myWalgreens account online at walgreens.com/mywdays. “We saw high engagement and a positive response from customers and team members for the July myW days event,” said Linh Peters, Walgreens Chief Marketing Officer. “We are building on this excitement.

Walgreens Unveils myW™ days Offers October 4 - 7

Ares Capital

Banco de Chile

British American Tobacco

Crown Castle International

Ecopetrol

Altria

Petroleo Brasileiro

Stellantis N.V. 

AT&T

Truist Financial

Vodafone Group

Western Gas Partners

Dogsofthedow.com recently published this list of 50 large-cap high-dividend stocks as of 9/28/23. The DOD list targeted investors who “don't want to simply focus on a high dividend yield only to discover that the stock price has plunged or that the corporation went belly-up”. Investors reduce volatility/risk by limiting high-dividend search to large well-established companies.

50 Large-Cap High-Yield Stocks For October

Burlington Stores

Dollar General

Right now, retail is undergoing a major shakeup. Consumer shopping habits have changed, perhaps permanently.

Don't Miss the Boom: 3 Retail Stocks Set to Explode Higher

Verizon

Washington Trust Bancorp

Market turmoil continues in 2023 due to higher interest rates and the Federal Reserve's actions to contain inflation. Dividend yields have climbed, particularly in interest rate-sensitive industries, presenting opportunities for income investors. Three undervalued high-yield stocks with reasonable valuations are Verizon Communications, Washington Trust Bancorp, and Walgreens Boots Alliance.

3 High Yield Stocks For Dividend Growth And Income

Growth stock and Big Cap 20 Cencora is approaching an all time high and a buy point. A long-term partnership with Walgreens is a tailwind.

Growth Stock Fortified By Walgreens Alliance, Hovers Near All-Time High

Best Buy

Macy's

With recession fears on the rise, now might be a good time to consider the top retail stocks to sell in 2023. Indeed, with retail buyer's consumption patterns shifting, many investors are beginning to take a step back.

3 Retail Stocks to Sell Before the Damage Is Done

Morgan Stanley

Constellation Brands

Wells Fargo

Advance Auto Parts

Diageo

Netflix

Paychex

Trade Desk

Take-Two Interactive Software

Workday

Here are some of the tickers on my radar for Thursday, Sept. 28, taken directly from my reporter's notebook.

Here are the 12 stocks Jim Cramer is watching, including a dire consumer forecast

Walgreens' market capitalization has fallen below its book value this year. The stock is trading even below the low point of Wall Street's price targets.

How Much Lower Can Walgreens Boots Alliance Stock Go?

Axon Enterprise

Visa

In 2020 and 2022, all the major market indices experienced two bear markets. In between, they enjoyed a period of incredible euphoria.

Investment Time Machine: 3 Growth Stocks for a Regret-Free 2033

NIKE

Walgreens' expansion efforts haven't boosted profits. Nike's growth has slowed, but it still retains a powerful brand.

Is It Time to Buy the Dow's 3 Worst-Performing Stocks This Year?

CVS Health

Rite Aid

All three of the nation's leading drugstore chains have different reasons for closing stores, but the downsizing prescription is the same.

Drugstore Downsizing: CVS, Walgreens And Rite Aid To Close Nearly 1,500 Stores

Verizon, Walgreens Boots Alliance, and 3M have dividends all yielding over 6%. Business fundamentals are deteriorating for all three companies.

4 Dow Stocks Are Down Over 15% in 2023. Here's My Top Pick of the 4 to Buy Now.

Emerson Electric

Coca-Cola

Lockheed Martin

Shell PLC

As the year began, institutional investors fled growth stocks to the relative safety of value stocks. In the second quarter, some of that money moved back to growth stocks.

7 Value Stocks That Should Be on Every Investor's Radar This Fall

Walgreens Boots Alliance, Inc. (NASDAQ:WBA ) TD Cowen's 8th Annual FutureHealth Conference September 21, 2023 3:00 PM ET Company Participants John Driscoll - Executive Vice President and President, U.S. Healthcare Conference Call Participants Charles Rhyee - TD Cowen Charles Rhyee Good afternoon. And thank you for joining us for the next session here at TD Cowen's 8th Annual Future Health Conference.

Walgreens Boots Alliance, Inc. (WBA) TD Cowen's 8th Annual FutureHealth Conference (Transcript)

Walgreens' (WBA) latest research findings highlight the importance of patients adhering to their therapy.

Walgreens (WBA) New Study Shows Medical Adherence Importance

Walgreens and CVS both sport dividend yields that are more than double the S&P 500 average. Both have been investing significantly in healthcare, which could put pressure on their financials.

CVS Health vs. Walgreens Boots Alliance: Which Is the Better Dividend Stock to Own?

Investors love dividend stocks because they not only provide dependable income but also give investors a great opportunity for solid total return.

The 5 Highest Yielding S&P 500 Stocks Pay 7% and Higher Dividends and May Be the Best Buys for Q4

Ares Commercial Real Estate

BrightSpire Capital

Cornerstone Strategic Value Fund Inc

Cornerstone Total Return Fund Inc

FS Credit Opportunities Corp

FS KKR Capital Corp

AG Mortgage Investment Trust

Realty Income Corp

Oxford Lane Capital

Pfizer

Prior to August 31, 2023, my Readers mentioned 37 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, these are ReFa/Ro. Ten analyst-target-estimated TOP-NET-GAIN Re/Fa/Ro: PFE, PBR, O, T, BRSP, BTI, PRB.A, VOD, WBA, and MITT, averaged 48.7% net gains from reader data collected 8/18/23. Ten analyst-target-augured August TOP-PRICE-UPSIDE reader faves & rogues (ReFa/Ro) were: MMM, KHC, BRSP, T, O, PFE, BTI, VOD, WBA, & MITT boasting a 46.54% average target price upside estimate.

Readers Post 32 August Dividend Buy Candidates

Retrospective cohort study compared adherence, healthcare cost and utilization. ORLANDO, Fla.

Walgreens, AllianceRx Walgreens Pharmacy Study of Non-Infused Biologics in Rheumatoid Arthritis Treatment Underscores Importance of Medication Adherence

WBA stock was trading at around $38 in early June 2022, just before the Fed started increasing rates, and is now 40% below that level, compared to 18% gains for the S&

Will Walgreens Stock Rebound To Its Pre-Inflation Shock Level Of Over $50?

Walgreens Boots Alliance faces significant challenges in its retail pharmacy model and profitability trajectory in the healthcare segment. Walgreens has experienced a significant selloff, reaching levels last seen in early 2009. I assessed that buyers have attempted to stem its massive capitulation last week. But it's too early to ascertain robust buying sentiments after the damage.

Walgreens: Don't Be Fooled - It's Cheap For A Reason

Intel

The Dow Jones Industrial Average has grown from 12 mostly industrial components to 30 diverse, multinational businesses since its inception in 1896. Because the Dow is a share price-weighted index, poor-performing components, or those with a low share price, are at risk of being shown the door.

News for Walgreens Stock (WBA)